Review



bicistronic expression vector px330 cas9  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Addgene inc bicistronic expression vector px330 cas9
    Bicistronic Expression Vector Px330 Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 3003 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bicistronic+expression+vector+px330+cas9/pX330-U6-Chimeric_BB-CBh-hSpCas9+(Plasmid+%2342230)/pm41708849-481-1-5
    Average 96 stars, based on 3003 article reviews
    bicistronic expression vector px330 cas9 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice.
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATG CTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATGCTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Plasmid Preparation:

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice.
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATG CTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATGCTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Sequencing:

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice.
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATG CTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATGCTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Microinjection:

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice.
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATG CTTCGGAGACTCA-3′) was directly used for microinjection. ..

    Article Title: In vivo base editing of Chd3 rescues behavioural abnormalities in mice
    Article Snippet: .. The bicistronic expression vector px330-Cas9 (Addgene, 42230) containing the Cas9 coding region and the sg sequence (5′-ACATATGCTTCGGAGACTCA-3′) was directly used for microinjection. ..



    Similar Products

    96
    Addgene inc bicistronic expression vector px330 cas9
    Bicistronic Expression Vector Px330 Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bicistronic+expression+vector+px330+cas9/pX330-U6-Chimeric_BB-CBh-hSpCas9+(Plasmid+%2342230)/pm41708849-481-1-5
    Average 96 stars, based on 1 article reviews
    bicistronic expression vector px330 cas9 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    Addgene inc px330 bicistronic expression vector expressing cas9
    Px330 Bicistronic Expression Vector Expressing Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bicistronic+expression+vector+px330+cas9/Cas9+sgRNA+vector+(Plasmid+%2368463)/us11666039-411-1-11
    Average 97 stars, based on 1 article reviews
    px330 bicistronic expression vector expressing cas9 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    96
    Addgene inc bicistronic expression vector px330 expressing s pyogenes cas9
    Figure 7. LGR5 Deletion in Human ESCs Abrogates ISL1 Induction and Cono-ventriculogenesis (A) Schema of the strategy for construction of human LGR5-KO ESCs using the <t>CRISPR/Cas9</t> system. (B) Human ESCs (ESO3) were transiently co-transfected with <t>pX330-gRNA1</t> and pX330-gRNA2. The panel indicates the genotyping of the transduced ESC clones, showing both homologous LGR5-KO clones (#1 and #2) and hetero-knockout clones (#3, #4, and #5). (C) RT-PCR confirmed the absence of LGR5 mRNA expression of the LGR5-KO ESC line-derived cells on day 3 in cardiac differentiation. (D) Human LGR5-KO ESCs exhibited their impaired cardiogenic phenotype. LGR5 deletion did not affect MESP1 expression but significantly attenuated LEF1 and ISL1 expression in the cardiac differentiating cells on day 3 and day 6, followed by lower CM (TNNT2+) induction ratios than in WT ESC-derived cells on day 6, 10, and 18. *p < 0.05 and **p < 0.01 between WT and LGR5-KO ESC-derived cells. (E) Among the induced ISL1+Lineage+ intermediate populations on day 6, the percentage and cell number of only the ISL1+TNNT2+ population were significantly decreased in the LGR5-KO than in WT ESC-derived cells, whereas other intermediate populations (ISL1+HCN4+, ISL1+SMMHC+, and ISL1+CD31+) were not affected. (F) The comparison of the CVM- and FVM-enriched genes’ (Figure 5B; Table S3) expression in between WT and LGR5-KO ESC-derived beating CMs harvested on day 14, analyzed by quantitative RT-PCR (qPCR). **p < 0.01 between WT and LGR5-KO ESC-derived cells. (G) qPCR gene expression heatmap of representative genes related to mesodermal and cardiac differentiation in various time stages between WT and LGR5-KO ESC-derived cells. (H) A top panel shows a novel and putative MESP1 binding site on the human LGR5 promoter locus and indicates the sequence divergences of the region among several mammalian species. Chromatin immunoprecipitation (ChIP) assays demonstrated that recruitment of MESP1 onto the above binding site on the LGR5 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom). This recruitment was not affected by LGR5 deletion. **p < 0.01, NS, not significant. (I) A top panel shows a novel and putative LEF1 binding site on the human ISL1 promoter locus and indicates the sequence divergences of the region among several mammalian species. ChIP assays demonstrated that recruitment of LEF1 onto the above binding site on the ISL1 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom); however, this recruitment was significantly prevented by LGR5 deletion. **p < 0.01. (D, E, F, H, and I) Error bars represent SEM. See also Figures S6 and S7.
    Bicistronic Expression Vector Px330 Expressing S Pyogenes Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bicistronic+expression+vector+px330+cas9/pX330-U6-Chimeric_BB-CBh-hSpCas9+(Plasmid+%2342230)/pm30713072-348-51-59
    Average 96 stars, based on 1 article reviews
    bicistronic expression vector px330 expressing s pyogenes cas9 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Addgene inc px330 bicistronic expression vector expressing cas9 synthetic single-guide rna
    Figure 7. LGR5 Deletion in Human ESCs Abrogates ISL1 Induction and Cono-ventriculogenesis (A) Schema of the strategy for construction of human LGR5-KO ESCs using the <t>CRISPR/Cas9</t> system. (B) Human ESCs (ESO3) were transiently co-transfected with <t>pX330-gRNA1</t> and pX330-gRNA2. The panel indicates the genotyping of the transduced ESC clones, showing both homologous LGR5-KO clones (#1 and #2) and hetero-knockout clones (#3, #4, and #5). (C) RT-PCR confirmed the absence of LGR5 mRNA expression of the LGR5-KO ESC line-derived cells on day 3 in cardiac differentiation. (D) Human LGR5-KO ESCs exhibited their impaired cardiogenic phenotype. LGR5 deletion did not affect MESP1 expression but significantly attenuated LEF1 and ISL1 expression in the cardiac differentiating cells on day 3 and day 6, followed by lower CM (TNNT2+) induction ratios than in WT ESC-derived cells on day 6, 10, and 18. *p < 0.05 and **p < 0.01 between WT and LGR5-KO ESC-derived cells. (E) Among the induced ISL1+Lineage+ intermediate populations on day 6, the percentage and cell number of only the ISL1+TNNT2+ population were significantly decreased in the LGR5-KO than in WT ESC-derived cells, whereas other intermediate populations (ISL1+HCN4+, ISL1+SMMHC+, and ISL1+CD31+) were not affected. (F) The comparison of the CVM- and FVM-enriched genes’ (Figure 5B; Table S3) expression in between WT and LGR5-KO ESC-derived beating CMs harvested on day 14, analyzed by quantitative RT-PCR (qPCR). **p < 0.01 between WT and LGR5-KO ESC-derived cells. (G) qPCR gene expression heatmap of representative genes related to mesodermal and cardiac differentiation in various time stages between WT and LGR5-KO ESC-derived cells. (H) A top panel shows a novel and putative MESP1 binding site on the human LGR5 promoter locus and indicates the sequence divergences of the region among several mammalian species. Chromatin immunoprecipitation (ChIP) assays demonstrated that recruitment of MESP1 onto the above binding site on the LGR5 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom). This recruitment was not affected by LGR5 deletion. **p < 0.01, NS, not significant. (I) A top panel shows a novel and putative LEF1 binding site on the human ISL1 promoter locus and indicates the sequence divergences of the region among several mammalian species. ChIP assays demonstrated that recruitment of LEF1 onto the above binding site on the ISL1 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom); however, this recruitment was significantly prevented by LGR5 deletion. **p < 0.01. (D, E, F, H, and I) Error bars represent SEM. See also Figures S6 and S7.
    Px330 Bicistronic Expression Vector Expressing Cas9 Synthetic Single Guide Rna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bicistronic+expression+vector+px330+cas9/Cas9+sgRNA+vector+(Plasmid+%2368463)/pmc06107581-247-22-25
    Average 90 stars, based on 1 article reviews
    px330 bicistronic expression vector expressing cas9 synthetic single-guide rna - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 7. LGR5 Deletion in Human ESCs Abrogates ISL1 Induction and Cono-ventriculogenesis (A) Schema of the strategy for construction of human LGR5-KO ESCs using the CRISPR/Cas9 system. (B) Human ESCs (ESO3) were transiently co-transfected with pX330-gRNA1 and pX330-gRNA2. The panel indicates the genotyping of the transduced ESC clones, showing both homologous LGR5-KO clones (#1 and #2) and hetero-knockout clones (#3, #4, and #5). (C) RT-PCR confirmed the absence of LGR5 mRNA expression of the LGR5-KO ESC line-derived cells on day 3 in cardiac differentiation. (D) Human LGR5-KO ESCs exhibited their impaired cardiogenic phenotype. LGR5 deletion did not affect MESP1 expression but significantly attenuated LEF1 and ISL1 expression in the cardiac differentiating cells on day 3 and day 6, followed by lower CM (TNNT2+) induction ratios than in WT ESC-derived cells on day 6, 10, and 18. *p < 0.05 and **p < 0.01 between WT and LGR5-KO ESC-derived cells. (E) Among the induced ISL1+Lineage+ intermediate populations on day 6, the percentage and cell number of only the ISL1+TNNT2+ population were significantly decreased in the LGR5-KO than in WT ESC-derived cells, whereas other intermediate populations (ISL1+HCN4+, ISL1+SMMHC+, and ISL1+CD31+) were not affected. (F) The comparison of the CVM- and FVM-enriched genes’ (Figure 5B; Table S3) expression in between WT and LGR5-KO ESC-derived beating CMs harvested on day 14, analyzed by quantitative RT-PCR (qPCR). **p < 0.01 between WT and LGR5-KO ESC-derived cells. (G) qPCR gene expression heatmap of representative genes related to mesodermal and cardiac differentiation in various time stages between WT and LGR5-KO ESC-derived cells. (H) A top panel shows a novel and putative MESP1 binding site on the human LGR5 promoter locus and indicates the sequence divergences of the region among several mammalian species. Chromatin immunoprecipitation (ChIP) assays demonstrated that recruitment of MESP1 onto the above binding site on the LGR5 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom). This recruitment was not affected by LGR5 deletion. **p < 0.01, NS, not significant. (I) A top panel shows a novel and putative LEF1 binding site on the human ISL1 promoter locus and indicates the sequence divergences of the region among several mammalian species. ChIP assays demonstrated that recruitment of LEF1 onto the above binding site on the ISL1 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom); however, this recruitment was significantly prevented by LGR5 deletion. **p < 0.01. (D, E, F, H, and I) Error bars represent SEM. See also Figures S6 and S7.

    Journal: Developmental cell

    Article Title: Population and Single-Cell Analysis of Human Cardiogenesis Reveals Unique LGR5 Ventricular Progenitors in Embryonic Outflow Tract.

    doi: 10.1016/j.devcel.2019.01.005

    Figure Lengend Snippet: Figure 7. LGR5 Deletion in Human ESCs Abrogates ISL1 Induction and Cono-ventriculogenesis (A) Schema of the strategy for construction of human LGR5-KO ESCs using the CRISPR/Cas9 system. (B) Human ESCs (ESO3) were transiently co-transfected with pX330-gRNA1 and pX330-gRNA2. The panel indicates the genotyping of the transduced ESC clones, showing both homologous LGR5-KO clones (#1 and #2) and hetero-knockout clones (#3, #4, and #5). (C) RT-PCR confirmed the absence of LGR5 mRNA expression of the LGR5-KO ESC line-derived cells on day 3 in cardiac differentiation. (D) Human LGR5-KO ESCs exhibited their impaired cardiogenic phenotype. LGR5 deletion did not affect MESP1 expression but significantly attenuated LEF1 and ISL1 expression in the cardiac differentiating cells on day 3 and day 6, followed by lower CM (TNNT2+) induction ratios than in WT ESC-derived cells on day 6, 10, and 18. *p < 0.05 and **p < 0.01 between WT and LGR5-KO ESC-derived cells. (E) Among the induced ISL1+Lineage+ intermediate populations on day 6, the percentage and cell number of only the ISL1+TNNT2+ population were significantly decreased in the LGR5-KO than in WT ESC-derived cells, whereas other intermediate populations (ISL1+HCN4+, ISL1+SMMHC+, and ISL1+CD31+) were not affected. (F) The comparison of the CVM- and FVM-enriched genes’ (Figure 5B; Table S3) expression in between WT and LGR5-KO ESC-derived beating CMs harvested on day 14, analyzed by quantitative RT-PCR (qPCR). **p < 0.01 between WT and LGR5-KO ESC-derived cells. (G) qPCR gene expression heatmap of representative genes related to mesodermal and cardiac differentiation in various time stages between WT and LGR5-KO ESC-derived cells. (H) A top panel shows a novel and putative MESP1 binding site on the human LGR5 promoter locus and indicates the sequence divergences of the region among several mammalian species. Chromatin immunoprecipitation (ChIP) assays demonstrated that recruitment of MESP1 onto the above binding site on the LGR5 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom). This recruitment was not affected by LGR5 deletion. **p < 0.01, NS, not significant. (I) A top panel shows a novel and putative LEF1 binding site on the human ISL1 promoter locus and indicates the sequence divergences of the region among several mammalian species. ChIP assays demonstrated that recruitment of LEF1 onto the above binding site on the ISL1 promoter was augmented on day 3 in cardiac differentiation (arrows, bottom); however, this recruitment was significantly prevented by LGR5 deletion. **p < 0.01. (D, E, F, H, and I) Error bars represent SEM. See also Figures S6 and S7.

    Article Snippet: The following sequences were selected as two single guide-RNAs (sgRNA) which target the first exon of LGR5 gene locus and have minimal off-target activity, using the CHOPCHOP software (http://chopchop.cbu.uib.no/): sgRNA1 (genomic location: Chr12, 71,440,110-71,440,091), 5’-CAGGAGCACACCGAGCCGGGAGG-3’ and sgRNA2 (genomic location: Chr12, 71,440,308- 71,440,289), 5’- GTGGGGAAGTACTTACAGGTAGG-3’ (Figure 7A). sgRNAs were cloned into a bicistronic expression vector pX330 expressing S. pyogenes Cas9 (Addgene, #42230), following previously published protocols (Cong et al., 2013).

    Techniques: CRISPR, Transfection, Clone Assay, Knock-Out, Reverse Transcription Polymerase Chain Reaction, Expressing, Derivative Assay, Comparison, Quantitative RT-PCR, Gene Expression, Binding Assay, Sequencing, Chromatin Immunoprecipitation